Here, we employed this imaging approach in conjunction with multi-parametric histological validation to determine the ability of MRI to “phenotype” VEGF-induced changes in the in vivo tumor microenvironment of noninvasive MCF-7 and invasive MDA-MB-231 human breast cancer xenografts engineered to overexpress human VEGF-A. The gene discussed is VEGFA; the disease is breast cancer.